184 related articles for article (PubMed ID: 17558910)
21. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity.
Yin H; Fang J; Liao L; Maeda H; Su Q
BMC Cancer; 2014 Jun; 14():436. PubMed ID: 24927633
[TBL] [Abstract][Full Text] [Related]
23. Importance of Heme Oxygenase-1 in Gastrointestinal Cancers: Functions, Inductions, Regulations, and Signaling.
Hemmati M; Yousefi B; Bahar A; Eslami M
J Gastrointest Cancer; 2021 Jun; 52(2):454-461. PubMed ID: 33484436
[TBL] [Abstract][Full Text] [Related]
24. Expression of COX-2 and HER-2 in colorectal cancer and their correlation.
Wu QB; Sun GP
World J Gastroenterol; 2015 May; 21(20):6206-14. PubMed ID: 26034355
[TBL] [Abstract][Full Text] [Related]
25. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
[TBL] [Abstract][Full Text] [Related]
26. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
27. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
29. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
[TBL] [Abstract][Full Text] [Related]
31. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
33. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
34. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
[TBL] [Abstract][Full Text] [Related]
35. Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas.
Yanagawa T; Omura K; Harada H; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
Oral Oncol; 2004 Jan; 40(1):21-7. PubMed ID: 14662411
[TBL] [Abstract][Full Text] [Related]
36. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
37. Characterization of cathepsin X in colorectal cancer development and progression.
Jechorek D; Votapek J; Meyer F; Kandulski A; Roessner A; Franke S
Pathol Res Pract; 2014 Dec; 210(12):822-9. PubMed ID: 25442015
[TBL] [Abstract][Full Text] [Related]
38. Heme oxygenase-1 has antitumoral effects in colorectal cancer: involvement of p53.
Andrés NC; Fermento ME; Gandini NA; Romero AL; Ferro A; Donna LG; Curino AC; Facchinetti MM
Exp Mol Pathol; 2014 Dec; 97(3):321-31. PubMed ID: 25236576
[TBL] [Abstract][Full Text] [Related]
39. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
40. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
